Robotic versus freehand CT-guided radiofrequency ablation of pulmonary metastases: a comparative cohort study.
Edward W Johnston, Jodie Basso, Francisca Silva, Arafat Haris, Robin L Jones, Nasir Khan, Helen Lawrence, Jakob Mathiszig-Lee, James McCall, David C Cunningham, Nicos Fotiadis
Author Information
Edward W Johnston: Interventional Radiology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK. Ed.Johnston@rmh.nhs.uk. ORCID
PURPOSE: Radiofrequency ablation (RFA) is a curative treatment option for small lung metastases, which conventionally involves multiple freehand manipulations until the treating electrode is satisfactorily positioned. Stereotactic and robotic guidance has been gaining popularity for liver ablation, although has not been established in lung ablation. The purpose of this study is to determine the feasibility, safety, and accuracy of robotic RFA for pulmonary metastases, and compare procedures with a conventional freehand cohort. METHODS: A single center study with prospective robotic cohort, and retrospective freehand cohort. RFA was performed under general anesthesia using high frequency jet ventilation and CT guidance. Main outcomes were (i) feasibility/technical success (ii) safety using Common Terminology Criteria for Adverse Events (iii) targeting accuracy (iv) number of needle manipulations for satisfactory ablation. Robotic and freehand cohorts were compared using Mann-Whitney U tests for continuous variables, and Fisher's exact for categorical variables. RESULTS: Thirty-nine patients (mean age 65 ± 13 years, 20 men) underwent ablation of 44 pulmonary metastases at single specialist cancer center between July 2019 and August 2022. 20 consecutive participants underwent robotic ablation, and 20 consecutive patients underwent freehand ablation. All 20/20 (100%) robotic procedures were technically successful, and none were converted to freehand procedures. There were 6/20 (30%) adverse events in the robotic cohort, and 15/20 (75%) in the freehand cohort (P = 0.01). Robotic placement was highly accurate with 6 mm tip-to-target distance (range 0-14 mm) despite out-of-plane approaches, with fewer manipulations than freehand placement (median 0 vs. 4.5 manipulations, P < 0.001 and 7/22, 32% vs. 22/22, 100%, P < 0.001). CONCLUSIONS: Robotic radiofrequency ablation of pulmonary metastases with general anesthesia and high frequency jet ventilation is feasible and safe. Targeting accuracy is high, and fewer needle/electrode manipulations are required to achieve a satisfactory position for ablation than freehand placement, with early indications of reduced complications.
Delpla A, de Baere T, Varin E, Deschamps F, Roux C, Tselikas L (2021) Role of thermal ablation in colorectal cancer lung metastases. Cancers (Basel) 13:908
[DOI: 10.3390/cancers13040908]
Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, Helmberger T, Gillams AR, Frilling A, Ambrogi M, Bartolozzi C, Mussi A (2008) Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). https://doi.org/10.1016/S1470-2045(08)70155-4
De Baère T, Palussière J, Aupérin A, Hakime A, Abdel-Rehim M, Kind M, Dromain C, Ravaud A, Tebboune N, Boige V, Malka D, Lafont C, Ducreux M (2006) Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240:587–596. https://doi.org/10.1148/radiol.2402050807
[DOI: 10.1148/radiol.2402050807]
Macchi M, Belfiore MP, Floridi C, Serra N, Belfiore G, Carmignani L, Grasso RF, Mazza E, Pusceddu C, Brunese L, Carrafiello G (2017) Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol. https://doi.org/10.1007/s12032-017-0946-x
[DOI: 10.1007/s12032-017-0946-x]
Chen S, Yang S, Xu S, Dong S (2020) Comparison between radiofrequency ablation and sublobar resections for the therapy of stage I non-small cell lung cancer: a meta-analysis. PeerJ 8:e9228
[DOI: 10.7717/peerj.9228]
Nguyenhuy M, Xu Y, Maingard J, Barnett S, Kok HK, Brooks M, Jhamb A, Asadi H, Knight S (2022) A systematic review and meta-analysis of patient survival and disease recurrence following percutaneous ablation of pulmonary metastasis. Cardiovasc Intervent Radiol 45:1102–1113. https://doi.org/10.1007/s00270-022-03116-z
[DOI: 10.1007/s00270-022-03116-z]
Hasegawa T, Takaki H, Kodama H, Yamanaka T, Nakatsuka A, Sato Y, Takao M, Katayama Y, Fukai I, Kato T, Tokui T, Tempaku H, Adachi K, Matsushima Y, Inaba Y, Yamakado K (2020) Three-year survival rate after radiofrequency ablation for surgically resectable colorectal lung metastases: a prospective multicenter study. Radiology 294:686–695. https://doi.org/10.1148/radiol.2020191272
[DOI: 10.1148/radiol.2020191272]
Kashima M, Yamakado K, Takaki H, Kodama H, Yamada T, Uraki J, Nakatsuka A (2011) Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center’s experiences. Am J Roentgenol 197:576–580. https://doi.org/10.2214/AJR.11.6408
[DOI: 10.2214/AJR.11.6408]
Anderson JM, Murchison J, Patel D (2003) CT-guided lung biopsy: factors influencing diagnostic yield and complication rate. Clin Radiol 58:791–797
[DOI: 10.1016/S0009-9260(03)00221-6]
Baère T De, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiére J (2015) Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. https://doi.org/10.1093/annonc/mdv037
Li G, Xue M, Chen W, Yi S (2018) Efficacy and safety of radiofrequency ablation for lung cancers: a systematic review and meta-analysis. Eur J Radiol 100:92–98
[DOI: 10.1016/j.ejrad.2018.01.009]
Tinguely P, Paolucci I, Ruiter SJS, Weber S, de Jong KP, Candinas D, Freedman J, Engstrand J (2021) Stereotactic and robotic minimally invasive thermal ablation of malignant liver tumors: a systematic review and meta-analysis. Front Oncol. https://doi.org/10.3389/fonc.2021.713685
[DOI: 10.3389/fonc.2021.713685]
Heerink WJ, Ruiter SJS, Pennings JP, Lansdorp B, Vliegenthart R, Oudkerk M, de Jong KP (2019) Robotic versus freehand needle positioning in CT-guided ablation of liver tumors: a randomized controlled trial. Radiology 290:826–832. https://doi.org/10.1148/radiol.2018181698
[DOI: 10.1148/radiol.2018181698]
Beyer LP, Pregler B, Nießen C, Schicho A, Haimerl M, Jung EM, Stroszczynski C, Wiggermann P (2016) Stereotactically-navigated percutaneous irreversible electroporation (IRE) compared to conventional IRE: a prospective trial. PeerJ 4:e2277
[DOI: 10.7717/peerj.2277]
Johnston EW, Basso J, Winfield J, McCall J, Khan N, Messiou C, Koh DM, Fotiadis N (2022) Starting CT-guided robotic interventional oncology at a UK centre. Br J Radiol 95(1134):20220217. https://doi.org/10.1259/bjr.20220217
[DOI: 10.1259/bjr.20220217]
Koethe Y, Xu S, Velusamy G, Wood BJ, Venkatesan AM (2014) Accuracy and efficacy of percutaneous biopsy and ablation using robotic assistance under computed tomography guidance: a phantom study. Eur Radiol 24:723–730. https://doi.org/10.1007/s00330-013-3056-y
[DOI: 10.1007/s00330-013-3056-y]
Venturini M, Cariati M, Marra P, Masala S, Pereira PL, Carrafiello G (2020) CIRSE standards of practice on thermal ablation of primary and secondary lung tumours. Cardiovasc Intervent Radiol 43:667–683
[DOI: 10.1007/s00270-020-02432-6]
Puijk RS, Ahmed M, Goldberg SN, Meijerink MR (2021) Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the sio and datecan initiative. Radiology 301:533–540. https://doi.org/10.1148/radiol.2021203715
[DOI: 10.1148/radiol.2021203715]
Cancer Therapy Evaluation Program (CTEP) (2017) Common Terminology Criteria for Adverse Events (CTCAE).v.5.0 [5x7]. Cancer Ther Eval Progr 155
Widmann G, Stoffner R, Sieb M, Bale R (2009) Target registration and target positioning errors in computer-assisted neurosurgery: proposal for a standardized reporting of error assessment. Int J Med Robot Comput Assist Surg 5:355–365
[DOI: 10.1002/rcs.271]
Schullian P, Johnston E, Laimer G, Putzer D, Eberle G, Amann A, Effenberger M, Maglione M, Freund MC, Loizides A, Bale R (2020) Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience. Eur Radiol. https://doi.org/10.1007/s00330-020-07409-0
[DOI: 10.1007/s00330-020-07409-0]
Kennedy SA, Milovanovic L, Dao D, Farrokhyar F, Midia M (2014) Risk factors for pneumothorax complicating radiofrequency ablation for lung malignancy: a systematic review and meta-analysis. J Vasc Interv Radiol 25:1671-1681.e1. https://doi.org/10.1016/j.jvir.2014.07.025
[DOI: 10.1016/j.jvir.2014.07.025]
Zhu JC, Yan TD, Glenn D, Morris DL (2009) Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg 87:1023–1028
[DOI: 10.1016/j.athoracsur.2008.11.017]
Gillams AR, Lees WR (2007) Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol 62:639–644
[DOI: 10.1016/j.crad.2007.02.005]
Hiraki T, Tajiri N, Mimura H, Yasui K, Gobara H, Mukai T, Hase S, Fujiwara H, Iguchi T, Sano Y (2006) Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 241:275–283
[DOI: 10.1148/radiol.2411051087]
Nour-Eldin N-EA, Naguib NNN, Saeed A-S, Ackermann H, Lehnert T, Korkusuz H, Vogl TJ (2009) Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms. Am J Roentgenol 193:W43–W48
[DOI: 10.2214/AJR.08.1457]
Xu S, Qi J, Li B, Bie ZX, Li YM, Li XG (2021) Risk prediction of pneumothorax in lung malignancy patients treated with percutaneous microwave ablation: development of nomogram model. Int J Hyperth 38:488–497. https://doi.org/10.1080/02656736.2021.1902000
[DOI: 10.1080/02656736.2021.1902000]
Beyer LP, Pregler B, Niessen C, Dollinger M, Graf BM, Müller M, Schlitt HJ, Stroszczynski C, Wiggermann P (2016) Robot-assisted microwave thermoablation of liver tumors: a single-center experience. Int J Comput Assist Radiol Surg 11:253–259. https://doi.org/10.1007/s11548-015-1286-y
[DOI: 10.1007/s11548-015-1286-y]
Yuan Z, Wang Y, Zhang J, Zheng J, Li W (2019) A meta-analysis of clinical outcomes after radiofrequency ablation and microwave ablation for lung cancer and pulmonary metastases. J Am Coll Radiol 16:302–314
[DOI: 10.1016/j.jacr.2018.10.012]
